A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
A phase 1/2 trial of BNT329 in advanced solid tumours, run by BioNTech SE, now recruiting.
Overview
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 is a phase 1/2 interventional study registered as NCT07186842 by BioNTech SE, with 245 participants planned, started 2025-11-18 and due to reach its primary completion in 2030-05. Interventions recorded: BNT329 and CA19-9-targeting monoclonal antibody.
Similar pages
not linked directly; found by shared links- TrialSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Shares BioNTech, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialEarly-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
Shares BioNTech, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPM8002 in the Treatment of Patients With Advanced Solid Tumors
Shares BioNTech, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Shares BioNTech, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
Shares BioNTech, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPlasmodium Immunotherapy for Advanced Malignant Solid Tumors
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialFirst-in-Human Study of ICT01 in Patients With Advanced Cancer
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.